- 11/05/2015 New Funding Boosts Research For Controlling TB, Malaria, Dengue And Leishmaniasis (CNS): An additional investment of US$ 10.7 million has been announced by Global Health Innovative Technology Fund (GHIT Fund) to find more effective tools to control and eliminate TB, malaria, dengue and leishmaniasis. Dr BT Slingsby, CEO of GHIT ;... view full article
Japan | Tuberculosis | Humans
Japan | Malaria | Humans
Japan | Dengue | Humans
Japan | Leishmaniasis | Humans